BRIGHT MINDS BIOSCIENCES INC. Increase Decrease Through Net Exchange Differences Rightofuse Assets
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Increase Decrease Through Net Exchange Differences Rightofuse Assets of CAD 96 for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets · last filed 2024-12-31
| Period end | Increase Decrease Through Net Exchange Differences Rightofuse Assets 12 month |
|---|---|
| 2024-09-30 | 96.00 CAD 20-F · filed 2024-12-31 |